- Home
- ARBB vs NERV Comparison
ARBB vs NERV Comparison
Compare ARBB & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- NERV
- Stock Information
- Founded
- ARBB 1997
- NERV 2007
- Country
- ARBB Singapore
- NERV United States
- Employees
- ARBB N/A
- NERV N/A
- Industry
- ARBB EDP Services
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- NERV Health Care
- Exchange
- ARBB Nasdaq
- NERV Nasdaq
- Market Cap
- ARBB 13.3M
- NERV 14.6M
- IPO Year
- ARBB 2023
- NERV 2014
- Fundamental
- Price
- ARBB $5.36
- NERV $5.33
- Analyst Decision
- ARBB Strong Buy
- NERV Hold
- Analyst Count
- ARBB 1
- NERV 1
- Target Price
- ARBB $20.00
- NERV $5.00
- AVG Volume (30 Days)
- ARBB 59.8K
- NERV 9.2M
- Earning Date
- ARBB 11-26-2025
- NERV 11-05-2025
- Dividend Yield
- ARBB N/A
- NERV N/A
- EPS Growth
- ARBB N/A
- NERV N/A
- EPS
- ARBB N/A
- NERV 1.48
- Revenue
- ARBB $24,425,491.00
- NERV N/A
- Revenue This Year
- ARBB N/A
- NERV N/A
- Revenue Next Year
- ARBB $462.92
- NERV N/A
- P/E Ratio
- ARBB N/A
- NERV $4.32
- Revenue Growth
- ARBB N/A
- NERV N/A
- 52 Week Low
- ARBB $3.92
- NERV $1.15
- 52 Week High
- ARBB $18.60
- NERV $12.46
- Technical
- Relative Strength Index (RSI)
- ARBB 39.77
- NERV 70.17
- Support Level
- ARBB $5.00
- NERV $2.41
- Resistance Level
- ARBB $6.96
- NERV $12.46
- Average True Range (ATR)
- ARBB 0.64
- NERV 0.77
- MACD
- ARBB -0.29
- NERV 0.34
- Stochastic Oscillator
- ARBB 9.23
- NERV 30.64
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.